Journal
DRUG DISCOVERY TODAY
Volume 22, Issue 2, Pages 454-462Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2016.11.003
Keywords
-
Categories
Funding
- NIH [HL52141, HL109212]
- Stanford University SPARK
- Stanford Graduate Fellowship
Ask authors/readers for more resources
Natural endogenously occurring peptides exhibit desirable medicinal properties, but are often limited in application by rapid proteolysis and inadequate membrane permeability. However, editing naturally occurring peptide sequences to develop peptidomimetic analogs created a promising class of therapeutics that can augment or inhibit molecular interactions. Here, we discuss a variety of chemical modifications, including L to D isomerization, cyclization, and unnatural amino acid substitution, as well as design strategies, such as attachment to cell-penetrating peptides, which are used to develop peptidomimetics. We also provide examples of approved peptidomimetics and discuss several compounds in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available